Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects:

Excluded studies with reasons for exclusion. by Si He (3236646)

Subjects:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. by Karl Ingard (22582091)

Subjects:

Flow diagram of the studies included in the meta-analysis. by Si He (3236646)

Subjects:

Inhibition of ferroptosis mitigated liver injury caused by <i>C. sinensis</i> infection. by Haoyang Zhang (1706815)

Subjects:

Liver ferroptosis caused by <i>C. sinensis</i> infection in mice by Haoyang Zhang (1706815)

Subjects:

SMR reveals common molecular patterns. by Daniela Fusco (10027975)

Subjects:

IRs -EGFP-N1 (red) in transfected HEK 293T cells assessed by confocal microscopy. by Ceyan Kuang (8554557)

Subjects:

Cinnamaldehyde repellency test within 6 hours in parthenogenesis <i>H. longicornis.</i> by Ceyan Kuang (8554557)

Subjects:

Credible sets and evidence of colocalization. by Daniela Fusco (10027975)

Subjects:

Identification of HL-IR. by Ceyan Kuang (8554557)

Subjects:

Transcriptome sequencing and differential analysis of <i>H. longicornis</i> at different developmental stages in response to cinnamaldehyde stimulation. by Ceyan Kuang (8554557)

Subjects:

Genetic correlations between sMRI traits and BMI. by Daniela Fusco (10027975)

Subjects:

Network of colocalized causal variants. by Daniela Fusco (10027975)

Subjects:

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”